This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
1g | $3000 | Check With Us |
500mg | $2000 | Check With Us |
Cat #: V4234 CAS #: 2023788-19-2 Purity ≥ 98%
Description: Tirzepatide (formerly known as LY3298176; trade name Mounjaro) is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved by FDA in May 2022 for the treatment of type 2 diabetes.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 4813.45 |
---|---|
Molecular Formula | C225H348N48O68 |
CAS No. | 2023788-19-2 |
Storage | -20℃ for 3 years in powder formrrr |
-80℃ for 2 years in solvent |
Protocol | In Vivo | Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 0.2078 mL | 1.0388 mL | 2.0775 mL | 4.1550 mL |
5mM | 0.0416 mL | 0.2078 mL | 0.4155 mL | 0.8310 mL |
10mM | 0.0208 mL | 0.1039 mL | 0.2078 mL | 0.4155 mL |
20mM | 0.0104 mL | 0.0519 mL | 0.1039 mL | 0.2078 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.